NeuroTargets Ltd

NeuroTargets Ltd is an innovative biopharmaceutical company that uses novel genes for the development of drug targets.  Active in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease.

Contact: Dr David Kennard, Chief Executive Officer